Hodogaya Chemical (4112) FY2026 Q3 Earnings Report

Quick View

Executive Summary

For the nine months ended Q3 of the fiscal year ending March 2026, the combination of declining revenue and deteriorating profitability in the core businesses resulted in a decline in operating income that extended to ordinary income and net income. Revenue was ¥344.5B (¥372.4B in the prior-year period, YoY -7.5%), operating income was ¥24.3B (¥45.8B, YoY -47.1%), ordinary income was ¥30.6B (¥46.8B, YoY -34.6%), and net income attributable to owners of the parent was ¥19.9B (¥28.8B, YoY -30.9%). The operating margin declined substantially to 7.0% from 12.3% in the prior-year period, with the primary cause of the earnings decline being the inability to fully absorb SG&A expenses amid lower revenue.

Factors Affecting Performance

【Revenue】Revenue was ¥344.5B, down 7.5% year on year, with external revenue falling below the prior-year level in all reported segments. Functional Colorants, the core business, generated ¥191.6B (55.6% of total revenue), down 6.3%; Functional Resins generated ¥55.9B, down 14.9%; Basic Chemicals generated ¥56.8B, down 3.5%; Agroscience generated ¥31.1B, down 9.7%; and Logistics-Related Operations generated ¥24.1B, down 2.1%. The broadening of the demand recovery remains limited.

【Profitability】The gross profit margin was maintained at 38.8%, but the SG&A ratio rose to 31.8%, causing negative operating leverage amid declining revenue. Functional Colorants recorded segment profit of ¥24.6B and accounted for a notably high proportion of profits, although this represented a substantial decline from the prior-year period. Functional Resins posted a loss of ¥3.8B, while Agroscience also fell into a loss of ¥1.2B. Logistics-Related Operations, with profit of ¥2.6B, and Basic Chemicals, with profit of ¥1.9B, provided support. Non-operating income of ¥8.1B (including dividend income of ¥3.7B and foreign exchange gains of ¥2.7B) supplemented ordinary income, resulting in the decline in ordinary income (-34.6%) being smaller than the decline in operating income (-47.1%). Both extraordinary income and extraordinary losses were ¥0.2B, indicating that the impact of temporary factors was limited. In conclusion, the company experienced declines in both revenue and earnings.

Segment Analysis

Functional Colorants generated revenue of ¥191.6B (55.6% of total revenue) and operating income of ¥24.6B, serving as the core of consolidated profits, although profitability declined from the high level recorded in the prior-year period. Functional Resins generated revenue of ¥55.9B, down 14.9% year on year, and fell into an operating loss of ¥3.8B. Basic Chemicals generated revenue of ¥56.8B and operating income of ¥1.9B, maintaining profitability despite lower revenue. Agroscience generated revenue of ¥31.1B and an operating loss of ¥1.2B, deteriorating from a profit in the prior year. Logistics-Related Operations generated revenue of ¥24.1B, operating income of ¥2.6B, and an operating margin of 10.7%, making it the most stable segment and partially absorbing fluctuations in the chemical business segments. Recovery in Functional Colorants’ profitability is the most important driver of consolidated performance.

Key Financial Metrics

【Profitability】The operating margin was 7.0%, a substantial decline from 12.3% in the prior-year period, while ROE remained at 5.2%. Although the gross profit margin was maintained at 38.8%, the SG&A ratio of 31.8% weighed on profitability.【Cash Flow Quality】Operating Cash Flow (OCF) was ¥51.4B, approximately 2.6 times net income attributable to owners of the parent of ¥19.9B, indicating strong cash conversion. EBITDA, including depreciation and amortization expense of ¥25.2B, was approximately ¥49.4B, while free cash flow of ¥16.4B was secured.【Investment Efficiency】Capital expenditures (cash purchase outlays) of ¥45.3B reached 1.8 times depreciation and amortization expense, indicating a high level of investment. Trade receivables increased by ¥8.1B and inventories increased by ¥1.7B, absorbing funds as working capital, suggesting room for improvement in capital efficiency.【Financial Soundness】The equity ratio was high at 72.8%, with current assets of ¥375.8B substantially exceeding current liabilities of ¥143.4B. Cash and deposits of ¥116.6B exceeded total interest-bearing debt, indicating a conservative and robust financial position.

Cash Flow Analysis

Operating Cash Flow (OCF) was ¥51.4B, an increase of +9.6% year on year, and remained above net income attributable to owners of the parent of ¥19.9B, indicating strong cash backing for earnings. In terms of working capital, trade receivables increased by ¥8.1B and inventories increased by ¥1.7B, absorbing funds, while the ¥2.6B increase in trade payables partially offset this effect. Income taxes paid amounted to ¥10.2B. Investing Cash Flow was an outflow of ¥35.0B, with capital expenditures continuing at a level exceeding depreciation and amortization expense of ¥25.2B. Financing Cash Flow was nearly flat at ¥0.1B, primarily consisting of proceeds from and repayments of long-term borrowings and dividend payments of ¥3.7B. Free cash flow, calculated as OCF less investing cash flow, was positive at ¥16.4B, indicating that the company continues to generate sufficient funds from operating activities to finance investment and shareholder returns.

Earnings Quality

The gap between ordinary income of ¥30.6B and net income attributable to owners of the parent of ¥19.9B was primarily attributable to net income attributable to non-controlling interests of ¥13.1B, reflecting the ownership structure of consolidated subsidiaries. Non-operating income of ¥8.1B included dividend income of ¥3.7B and foreign exchange gains of ¥2.7B. While non-core factors supported ordinary income, the earnings decline arising from deteriorating profitability in Functional Colorants, Functional Resins, and Agroscience has a structural nature. Extraordinary income and extraordinary losses were each only ¥0.2B, indicating that temporary factors did not materially affect performance. OCF exceeded net income attributable to owners of the parent, indicating limited accruals—the divergence between accounting earnings and cash flows—and generally good earnings quality. However, increases in trade receivables and inventories indicate working capital accumulation, requiring monitoring of cash collection capacity during any recovery in profitability.

Earnings Forecast and Guidance

The full-year company forecasts are revenue of ¥470.0B, operating income of ¥35.0B, and ordinary income of ¥35.0B. The nine-month cumulative progress rates were 73.3% for revenue and 69.3% for operating income, both below the standard quarterly progress rate of 75%. The ordinary income progress rate was somewhat high at 87.5%, largely due to the contribution of non-operating income, including dividend income and foreign exchange gains. This should therefore be evaluated separately from the delayed progress in core operating income. Operating income must increase by more than ¥10B in Q4, making recovery in profitability centered on Functional Colorants the focal point for achieving the plan. No revisions were made to the earnings forecast or dividend forecast during the quarter.

Shareholder Returns

The Q2 dividend was ¥25.00 per share, and the full-year dividend forecast is ¥50.00, representing an increase from the previous fiscal year’s actual dividend of ¥45 (before considering the stock split). The forecast payout ratio, calculated using forecast net income of ¥20.0B and the average number of shares outstanding during the period of 15.90M shares, is approximately 39.8%, remaining below the generally accepted benchmark of 60%. Share buybacks were minimal at ¥0.0B, and shareholder returns are centered on dividends. Given cash and deposits of ¥116.6B and free cash flow of ¥16.4B, the company has ample resources to fund dividends for the time being.

Risk Factors

1. Deterioration in profitability of core segments: Functional Colorants is the core business, generating more than half of consolidated profits, but its earnings declined year on year. Functional Resins (-¥3.8B) and Agroscience (-¥1.2B) fell into operating losses, and continued deterioration in profitability across multiple businesses could affect achievement of the full-year operating income forecast of ¥35.0B.

2. Working capital accumulation: Trade receivables increased by ¥8.1B and inventories increased by ¥1.7B. If inventory accumulation or longer collection periods emerge during a demand adjustment phase, future cash-generating capacity could be constrained.

3. Dependence on non-operating income: Ordinary income was supported by non-operating income of ¥8.1B, including dividend income of ¥3.7B and foreign exchange gains of ¥2.7B. If foreign exchange conditions or the dividend policies of investees change, the supporting effect on ordinary income may weaken.

Industry Benchmark (For Reference; Compiled by the Company)

Profitability and Returns

The operating margin is slightly below the industry median, while the net profit margin is above the industry median.

Growth and Capital Efficiency

The revenue growth rate is substantially below the industry median, with the extent of the revenue decline standing out even within the industry.

※Source: Compiled by the company

Key Takeaways from the Earnings Results

1. Although the operating margin declined substantially year on year, OCF reached approximately 2.6 times net income attributable to owners of the parent, indicating good earnings quality from the perspective of cash conversion.

2. The trend in Functional Colorants’ profit margin is the largest variable affecting consolidated performance, and recovery in the segment’s profitability will be the key to achieving the full-year operating income forecast.

3. The strength of the financial foundation, reflected in an equity ratio of 72.8% and cash and deposits of ¥116.6B, demonstrates resilience during a performance adjustment phase. Meanwhile, trends in working capital, including increases in trade receivables and inventories, require monitoring.

Theoretical Share Price (Reference Value)

Sensitivity: ¥3,233–¥3,419 at ±1% for the cost of equity, and ¥3,302–¥3,338 at ±0.1 for ω.

Notes:

• Amortization of goodwill of ¥0.7 per share is added back to earnings (to account for a non-cash expense and comparability with IFRS companies).
• Since progress of net income against the full-year forecast (100%) exceeds the standard level (75%), forecast EPS is adjusted upward within a maximum range of +10% (because companies whose progress is ahead of plan tend to exceed forecasts; the adjustment may be excessive for businesses with strong seasonality).
• Since forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the end of the quarter are used (there is a timing difference from the full-year forecast).
• Since net assets include non-controlling interests, the theoretical value may be calculated at a somewhat higher level.

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; it is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI through analysis of XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, and, where necessary, after consulting with a professional advisor.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q3 performance was weak operationally, with revenue and operating profit declining and the full-year earnings target relying heavily on Q4 delivery. Cumulative revenue fell 7.5% YoY to ¥34.45bn. Operating income declined 47.1% to ¥2.43bn, materially underperforming the sales trend. Ordinary income fell a less severe 34.6% to ¥3.06bn, supported by non-operating income of ¥0.81bn. Net income attributable to owners of the parent decreased 30.9% to ¥1.99bn. The operating margin compressed by 5.3 percentage points to 7.0% from 12.3% in the prior-year period. Gross margin declined by 2.7 percentage points to 38.8%, indicating that the earnings deterioration was not solely a fixed-cost operating-leverage effect. SG&A rose 0.6% YoY despite the revenue decline, further intensifying margin pressure. Functional Dyes, the core business by operating-profit contribution, remained profitable but saw segment profit decline 38.6% YoY to ¥2.46bn. Functional Resins and AgroScience each moved into segment losses, creating the principal drag on consolidated operating profit. Cash conversion was strong: operating cash flow of ¥5.14bn was 2.58x profit attributable to owners and exceeded EBITDA of ¥4.94bn by 4%. Free cash flow was positive at ¥1.64bn after ¥3.50bn of investing cash outflow. The balance sheet remains conservative, with a 262.1% current ratio, 0.37x debt-to-equity ratio, and ¥11.66bn of cash and deposits. Nevertheless, long-term borrowings rose 43.5% YoY to ¥4.43bn, while 53.1% of interest-bearing debt is short term, requiring continued refinancing discipline. Working-capital efficiency is a material operational risk, as the supplied quality alerts identify receivable days of 88 days and 115 days, inventory days of 179 days and 115 days, and a 200-day cash-conversion cycle; each cited level is above the relevant warning threshold. Full-year guidance implies a sharp Q4 operating-income recovery, while the parent-attributable profit target is nearly achieved by Q3, suggesting that earnings mix, tax effects, and non-controlling interests will be important to the final result. The ¥50 full-year DPS forecast, adjusted for the April 2025 two-for-one stock split, appears affordable on forecast parent earnings and current free-cash-flow generation.

Profitability Analysis

The reported annualized DuPont ROE is 4.2%, decomposed into a 5.8% net profit margin, 0.525x annualized asset turnover, and 1.37x financial leverage. The modest leverage multiplier confirms that returns are predominantly constrained by operating profitability and asset efficiency rather than by an aggressive capital structure. The largest adverse development is the operating-margin decline to 7.0% from 12.3% a year earlier, reflecting both the 2.7 percentage-point gross-margin contraction and SG&A rising 0.6% while revenue declined 7.5%. EBITDA declined to ¥4.94bn and the EBITDA margin was 14.3%; this remains above the EBIT margin because depreciation and amortization totaled ¥2.52bn. JGAAP goodwill amortization was only ¥0.008bn, or 0.2% of EBITDA, and therefore does not materially distort comparison of EBITDA with operating income. The 5-factor analysis shows an interest burden of 1.265x, meaning that non-operating income more than offset financing costs; dividend income of ¥0.37bn and FX gains of ¥0.27bn were key contributors. This support improved ordinary income relative to operating income but should not be treated as a substitute for restoring segment-level operating profitability. The tax burden was 0.649x, while a ¥0.23bn income-tax benefit contributed to post-tax earnings. Functional Dyes was the core business, generating ¥18.94bn of external sales and ¥2.46bn of segment profit, down 6.3% and 38.6% YoY, respectively; its margin fell to 13.0% from 19.8%. Functional Resins reported ¥5.39bn of sales, down 14.9% YoY, and a ¥0.38bn segment loss versus essentially breakeven profit in the prior year. Basic Chemicals posted ¥5.57bn of sales, down 3.5%, and ¥0.19bn of profit, down 27.2%, with margin declining to 3.4% from 4.5%. AgroScience recorded ¥3.11bn of sales, down 9.7%, and a ¥0.12bn loss compared with ¥0.06bn profit previously. Logistics sales declined 2.1% to ¥1.33bn, but segment profit improved marginally to ¥0.26bn and its margin expanded to 19.4% from 18.8%. The present profit profile is sustainable only if the Functional Dyes margin stabilizes and losses in Functional Resins and AgroScience are reversed; non-operating investment income and FX gains cannot reliably close an operating shortfall.

Growth Assessment

Revenue contraction was broad-based across all five reportable segments, which points to a group-wide demand, pricing, or volume challenge rather than a single isolated weakness. Functional Dyes accounted for 55.0% of consolidated external sales and therefore remains the main determinant of revenue and profit recovery. Functional Resins experienced the steepest sales decline among the main businesses and shifted to a loss, making its turnaround central to incremental earnings recovery. AgroScience also shifted to a loss, indicating that sales recovery alone may be insufficient without improved product mix or cost absorption. Basic Chemicals remained profitable but at a low 3.4% margin, leaving it exposed to modest changes in selling prices, energy costs, and input costs. Logistics provides relatively stable profitability but contributed only 10.6% of consolidated segment profit and cannot offset weakness in Functional Dyes. FY2026 full-year guidance calls for revenue of ¥47.00bn, operating income of ¥3.50bn, ordinary income of ¥3.50bn, and parent-attributable net income of ¥2.00bn. Q3 cumulative progress is 73.3% for sales, 69.3% for operating income, 87.5% for ordinary income, and 99.6% for parent-attributable profit, against a standard 75% Q3 progress rate. Operating-income progress is 5.7 percentage points below the seasonal benchmark, although not more than 10 percentage points below it. Achieving guidance requires Q4 revenue of ¥12.55bn and operating income of ¥1.07bn, equivalent to an 8.5% Q4 operating margin versus the 7.0% cumulative margin. It also requires ordinary income of ¥0.44bn and only ¥0.01bn of additional parent-attributable profit, illustrating that the forecasted Q4 profit mix differs substantially from the operating-profit requirement. The outlook is therefore dependent on meaningful fourth-quarter operating-margin recovery and on the allocation of earnings between parent shareholders and non-controlling interests. Foreign-exchange gains of ¥0.27bn, equal to 11.1% of operating income, provided a meaningful but non-core benefit and leave reported ordinary earnings exposed to currency movements.

Financial Health

Liquidity is strong. Current assets of ¥37.58bn exceed current liabilities of ¥14.34bn, producing working capital of ¥23.24bn and a 262.1% current ratio. The 200.4% quick ratio indicates that liquidity does not depend solely on inventory monetization. Cash and deposits of ¥11.66bn cover short-term loans of ¥5.03bn by 2.32x. Total interest-bearing debt was ¥9.46bn, equivalent to 0.37x total equity and 12.9% of capital, both conservative levels. Debt/EBITDA of 1.91x is within the stated investment-grade benchmark, while EBITDA interest coverage of 63.36x and EBIT interest coverage of 31.10x indicate ample debt-service capacity. Long-term loans increased ¥1.34bn, or 43.5% YoY, to ¥4.43bn; this was partly associated with ¥2.00bn of new long-term borrowing during the period, offset by ¥1.04bn of repayments. The increase in long-term funding does not presently threaten solvency, but it raises the importance of ensuring that debt-funded investment produces adequate operating returns. The REFINANCING_RISK alert requires attention because 53.1% of debt is short term, above the 40% alert threshold. In context, the cash-to-short-term-debt ratio of 2.32x and strong current ratio substantially mitigate near-term maturity mismatch risk. However, reduced earnings and elevated working-capital requirements could diminish that cushion if they persist. Total equity increased to ¥63.67bn from ¥58.53bn, supported by accumulated other comprehensive income; the company therefore retains considerable balance-sheet loss-absorption capacity. Investment securities represent 14.0% of total assets, and changes in market valuations contributed to comprehensive income, creating some exposure of equity to financial-market movements. Asset-retirement obligations total ¥0.16bn, or roughly 0.7% of liabilities, which is modest for a chemical manufacturer. Non-controlling interests of ¥11.22bn are significant, so consolidated net income should be distinguished from earnings attributable to owners when assessing shareholder returns.

Notable B/S Changes

Long-term loans: +¥1.34bn (+43.5%) to ¥4.43bn - long-term funding increased while operating profit weakened; monitor deployment returns and interaction with the 53.1% short-term debt share. Total assets: +¥7.62bn (+9.5%) to ¥87.48bn - growth was led by noncurrent assets, including PPE and investment securities, increasing the importance of asset productivity. PPE: +¥3.23bn (+10.9%) to ¥32.74bn - capital intensity rose to 37.4% of assets, making utilization and returns on invested capital important for future profitability. Investment securities: +¥2.24bn (+19.9%) to ¥12.26bn - sizeable portfolio exposure contributed to comprehensive-income sensitivity and represents 14.0% of total assets. Total equity: +¥5.14bn (+8.8%) to ¥63.67bn - stronger equity capitalization supports solvency, partly reflecting positive valuation and translation movements.

Cash Flow Quality

Cash-flow quality was strong during the nine-month period. Operating cash flow rose to ¥5.14bn from ¥4.69bn and was 2.58x parent-attributable net income of ¥1.99bn, well above the 1.0x high-quality benchmark and not indicative of an OCF-versus-earnings concern. OCF also equaled 1.04x EBITDA, demonstrating full cash conversion of EBITDA. The accruals ratio was negative 3.6%, consistent with favorable cash realization rather than an accumulation of non-cash earnings. Operating cash flow benefited from a ¥0.81bn reduction in trade receivables and a ¥0.26bn increase in trade payables, while inventories increased by ¥0.17bn. These movements supported reported cash generation but do not negate the structural working-capital concerns indicated by the quality alerts. Specifically, the HIGH_RECEIVABLE_DAYS flags identify DSO of 88 days and 115 days, each above warning thresholds; slow collections can increase credit risk and make operating cash flow more volatile. The HIGH_INVENTORY_DAYS flags identify DIO of 179 days and 115 days, each well above manufacturing warning thresholds; this indicates material capital tied up in stock and increases obsolescence, valuation, and demand-forecast risk. The LONG_CCC alert of 200 days, above the 120-day warning threshold, combines slow collection and inventory conversion with a prolonged cash cycle. This is not typical of an efficient manufacturing working-capital profile and is particularly important in chemicals, where demand changes, product specifications, and raw-material cost swings can impair inventory recoverability. Investing cash flow was ¥3.50bn, including ¥4.53bn of purchases of property, plant, and equipment and intangibles. As a result, free cash flow remained positive at ¥1.64bn, providing internal funding for dividends and a portion of investment needs. Cash and cash equivalents increased ¥1.89bn to ¥9.49bn, while total cash and deposits were ¥11.66bn, further evidencing solid period cash generation. The key issue is not near-term cash sufficiency but whether the high inventory and receivable intensity can be reduced without impairing sales or margins.

Dividend Sustainability

The company forecasts a full-year dividend of ¥50 per share, comprising the ¥25 interim dividend and an implied ¥25 year-end dividend. The forecast DPS should be assessed on the post-split basis because the company implemented a two-for-one stock split effective April 1, 2025. Against forecast EPS of ¥125.86, the implied dividend-only payout ratio is approximately 39.7%, below the 60% sustainability benchmark. The supplied 21.1% calculation reflects the paid ¥25 interim dividend relative to a different earnings base and should not be interpreted as the full-year payout ratio. Current-period free cash flow of ¥1.64bn covers the interim dividend cash requirement of approximately ¥0.40bn by about 4.1x, broadly consistent with the supplied 3.89x FCF coverage metric. On a full-year ¥50 DPS basis, total dividend cash would be approximately ¥0.80bn using issued shares, leaving positive residual free cash flow at the current run rate. Share repurchases were immaterial at ¥0.001bn, so the distinction between dividend payout ratio and total return ratio has no practical effect in this period. Dividend affordability is supported by modest leverage, strong interest coverage, and cash exceeding short-term debt. The main constraint on future dividend growth is the decline in operating earnings, rather than liquidity. Sustainable distributions will depend on restoring operating-margin performance and preventing working-capital needs from absorbing cash flow.

Risk Assessment

Business risks include High priority: Functional Dyes profit fell 38.6% YoY to ¥2.46bn despite only a 6.3% sales decline, demonstrating significant margin sensitivity in the core business., High priority: Functional Resins and AgroScience moved from profit to losses of ¥0.38bn and ¥0.12bn, respectively; delayed recovery in these businesses would limit consolidated margin normalization., High priority: The 200-day cash-conversion cycle, alongside supplied DSO alerts of 88 and 115 days and DIO alerts of 179 and 115 days, raises inventory-obsolescence, collection, and cash-absorption risk., Medium priority: As a chemical manufacturer, the group remains exposed to raw-material, energy, and selling-price volatility, particularly in low-margin Basic Chemicals., Medium priority: FX gains of ¥0.27bn supported ordinary income; currency movements can reverse this support and add volatility to earnings., Medium priority: Asset values and comprehensive income are exposed to valuation movements in the ¥12.26bn investment-securities portfolio..

Financial risks include Medium priority: 53.1% of interest-bearing debt is short term, triggering the refinancing-risk alert. Liquidity mitigates the immediate risk, but maturities should be monitored if operating cash conversion weakens., Medium priority: Long-term loans increased 43.5% YoY to ¥4.43bn. The associated investments need to earn returns above funding costs and support future profitability., Low priority: No immediate solvency stress is evident, given 0.37x debt-to-equity, 1.91x debt/EBITDA, 262.1% current ratio, and 63.36x EBITDA interest coverage..

Key concerns include The full-year operating-income forecast requires a ¥1.07bn Q4 contribution and an 8.5% Q4 operating margin, above the 7.0% nine-month margin., The annualized ROE of 4.2% is below the 8% concern threshold, reflecting weak profitability and only moderate asset turnover., Non-operating dividend income and FX gains supported ordinary income, but they do not resolve the underlying operating-margin decline., The supplied working-capital quality alerts contain multiple high day-count readings; all are warning-level and indicate that working-capital efficiency warrants close scrutiny..

Investment Implications

Key takeaways include Revenue fell 7.5% YoY and operating income fell 47.1% YoY, with operating margin compressing to 7.0%., Functional Dyes remains the earnings engine but suffered substantial margin compression; Functional Resins and AgroScience losses are the most visible turnaround requirements., Cash earnings were strong, with ¥5.14bn operating cash flow, ¥1.64bn free cash flow, 2.58x OCF/parent-attributable income, and 1.04x OCF/EBITDA., Balance-sheet risk is contained by high liquidity and low leverage, although short-term debt concentration and the 43.5% increase in long-term loans merit monitoring., Forecast attainment depends on a Q4 operating-margin rebound, whereas parent-attributable profit is already at 99.6% of full-year guidance..

Metrics to watch include Functional Dyes segment margin and whether its earnings decline moderates, Functional Resins and AgroScience return to segment profitability, Q4 operating income of ¥1.07bn implied by unchanged full-year guidance, Receivable days, inventory days, and cash-conversion-cycle improvement, Long-term borrowing usage and the share of debt maturing within one year, Contribution of dividend income and FX effects to ordinary income, Free cash flow after capital expenditure and full-year dividend coverage.

Regarding relative positioning, The company combines a conservative balance sheet, strong interest coverage, and solid current-period cash conversion with sub-benchmark annualized ROE and a materially weakened operating margin. Relative financial resilience is therefore stronger than relative earnings momentum; the central analytical issue is operating recovery and working-capital efficiency rather than immediate liquidity or covenant risk.